Literature DB >> 2899638

Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.

E Johansson1, S Agurell, L E Hollister, M M Halldin.   

Abstract

The aim of this study was to characterize the elimination half-life of delta 1-tetrahydrocannabinol in blood plasma in chronic marijuana users. The subjects smoked four cigarettes during a two day period, each cigarette containing 15 mg deuterium-labelled delta 1-tetrahydrocannabinol. The plasma concentrations of deuterium-labelled tetrahydrocannabinol were measured for 13 days using gas chromatography-mass spectrometry equipped with selected ion monitoring. The elimination half-life for delta 1-tetrahydrocannabinol in blood plasma was calculated to be 4.1 +/- 1.1 days (range 2.9-5.0 days) from the two week plasma level curves. Albeit the present results are based upon a small sample, an elimination half-life of delta 1-tetrahydrocannabinol in blood plasma of about 4 days is more in line with apparent half-life excretion of delta 1-tetrahydrocannabinol metabolites in the urine of chronic marijuana smokers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899638     DOI: 10.1111/j.2042-7158.1988.tb05272.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 2.  The acute effects of cannabinoids on memory in humans: a review.

Authors:  Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-09-26       Impact factor: 4.530

3.  Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.

Authors:  Dayong Lee; Mateus M Bergamaschi; Garry Milman; Allan J Barnes; Regina H C Queiroz; Ryan Vandrey; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

4.  Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.

Authors:  Erin L Karschner; Madeleine J Swortwood; Jussi Hirvonen; Robert S Goodwin; Wendy M Bosker; Johannes G Ramaekers; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-06-11       Impact factor: 3.345

5.  Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Authors:  E Johansson; M M Halldin; S Agurell; L E Hollister; H K Gillespie
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Postmortem redistribution of THC in the pig.

Authors:  Bertrand Brunet; Thierry Hauet; William Hébrard; Yves Papet; Gérard Mauco; Patrick Mura
Journal:  Int J Legal Med       Date:  2010-01-07       Impact factor: 2.686

7.  Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.

Authors:  Mateus M Bergamaschi; Erin L Karschner; Robert S Goodwin; Karl B Scheidweiler; Jussi Hirvonen; Regina H C Queiroz; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-03       Impact factor: 8.327

8.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

9.  Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.

Authors:  Alfonso Romero-Sandoval; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Anesthesiology       Date:  2008-04       Impact factor: 7.892

10.  Association of marijuana use and the incidence of testicular germ cell tumors.

Authors:  Janet R Daling; David R Doody; Xiaofei Sun; Britton L Trabert; Noel S Weiss; Chu Chen; Mary L Biggs; Jacqueline R Starr; Sudhansu K Dey; Stephen M Schwartz
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.